T1	Entity 24 28	ESR1
T2	SNP 29 38	rs2881766
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Effect_Type 39 48	increases
T4	Association 63 67	risk
E1	Association:T4 bc:T5
R2	Effect_type_marker Arg1:E1 Arg2:T3	
T5	Cancer 49 62	breast cancer
A1	Effect_Type E1 Increase
T6	Entity 71 83	Korean women
R3	Population_assignment Arg1:T2 Arg2:T6	
T7	Spec 123 131	evaluate
T8	Association 136 147	association
E2	Association:T8 snp_int:T9 bc:T10
R4	Speculation_marker Arg1:E2 Arg2:T7	
T9	SNP 159 172	polymorphisms
T10	Cancer 244 257	breast cancer
T11	Entity 176 210	estrogen-metabolizing enzyme genes
T12	Entity 215 238	estrogen receptor genes
R5	SNP_coupled_gene Arg1:T9 Arg2:T11	
R6	SNP_coupled_gene Arg1:T9 Arg2:T12	
T13	Entity 302 314	Korean women
R7	Population_assignment Arg1:T9 Arg2:T13	
T14	Entity 276 285	age group
R8	Risk_Factor Arg1:T9 Arg2:T14	
T15	Entity 500 528	premenopausal under 35 years
T16	Entity 539 566	premenopausal over 35 years
T17	Entity 582 596	postmenopausal
R10	Equiv Arg1:T14 Arg2:T38	
T18	Cancer 677 686	luminal A
A2	Cancer_Type T18 Horm+HER2-Ki67Low
T19	Cancer 688 697	luminal B
A3	Cancer_Type T19 Horm+HER2-Ki67+
T20	Cancer 699 718	HER2-overexpressing
A4	Cancer_Type T20 HER2+
T21	Cancer 724 739	triple-negative
A5	Cancer_Type T21 TNBC_and_or_Basal_like
R12	Member Arg1:T10 Arg2:T21	
R13	Member Arg1:T10 Arg2:T20	
R14	Member Arg1:T10 Arg2:T19	
R15	Equiv Arg1:T10 Arg2:T18	
T22	Entity 1053 1057	ESR1
T23	SNP 1059 1068	rs2881766
T24	SNP 1070 1079	rs2077647
T25	SNP 1081 1089	rs926778
T26	SNP 1095 1104	rs2273206
R16	SNP_coupled_gene Arg1:T23 Arg2:T22	
T27	SNP 1153 1162	rs3798377
T28	Effect_Type 1163 1172	decreased
T29	Effect_Type 1119 1128	increased
T30	Cancer 1129 1142	breast cancer
R17	SNP_coupled_gene Arg1:T24 Arg2:T22	
R18	SNP_coupled_gene Arg1:T25 Arg2:T22	
R19	SNP_coupled_gene Arg1:T26 Arg2:T22	
T31	Association 1143 1147	risk
E3	Association:T31 bc:T30 snp_int:T26 snp_int2:T25 snp_int3:T24 snp_int4:T23
A6	Effect_Type E3 Increase
R20	Effect_type_marker Arg1:E3 Arg2:T29	
T32	Association 1177 1181	risk
E4	Association:T32 snp_int:T27 bc:T30
R21	Effect_type_marker Arg1:E4 Arg2:T28	
A7	Effect_Type E4 Decrease
T33	SNP 1337 1346	rs2881766
T34	Effect_Type 1347 1356	increased
T35	Entity 1383 1403	all three age groups
R23	Risk_Factor Arg1:T33 Arg2:T35	
T36	Association 1371 1375	risk
E5	Association:T36 snp_int:T33 bc:T37
A8	Effect_Type E5 Increase
R24	Effect_type_marker Arg1:E5 Arg2:T34	
T37	Cancer 1357 1370	breast cancer
T38	Entity 486 498	three groups
R25	Member Arg1:T38 Arg2:T15	
R26	Member Arg1:T38 Arg2:T16	
R27	Member Arg1:T38 Arg2:T17	
R9	Equiv Arg1:T35 Arg2:T38	
T39	SNP 1409 1417	rs926778
T40	Effect_Type 1418 1427	increased
T41	Association 1432 1436	risk
E6	Association:T41 snp_int:T39 bc:T37
A9	Effect_Type E6 Increase
R11	Effect_type_marker Arg1:E6 Arg2:T40	
T42	Entity 1440 1467	premenopausal over 35 years
R28	Population_assignment Arg1:T23 Arg2:T13	
R29	Population_assignment Arg1:T24 Arg2:T13	
R30	Population_assignment Arg1:T25 Arg2:T13	
R31	Population_assignment Arg1:T26 Arg2:T13	
R32	Population_assignment Arg1:T27 Arg2:T13	
R33	Population_assignment Arg1:T33 Arg2:T13	
R34	Population_assignment Arg1:T39 Arg2:T13	
R35	Risk_Factor Arg1:T39 Arg2:T42	
T43	Entity 1481 1495	postmenopausal
R36	Population_assignment Arg1:T39 Arg2:T43	
T44	SNP 1527 1536	rs2881766
T45	Effect_Type 1537 1546	increased
T46	Cancer 1547 1560	breast cancer
R37	Population_assignment Arg1:T44 Arg2:T13	
T47	Association 1561 1565	risk
E7	Association:T47 bc:T46 snp_int:T44
A10	Effect_Type E7 Increase
R38	Effect_type_marker Arg1:E7 Arg2:T45	
T48	Cancer 1575 1584	luminal A
T49	Cancer 1586 1605	HER2-overexpressing
T50	Cancer 1611 1626	triple-negative
T51	Neg 1636 1646	except for
T52	Cancer 1647 1656	luminal B
R39	Negation_marker Arg1:T52 Arg2:T51	
T53	SNP 1670 1678	rs926778
R40	Population_assignment Arg1:T53 Arg2:T13	
T54	Effect_Type 1679 1688	increased
T55	Association 1693 1697	risk
E8	Association:T55 snp_int:T53 bc:T56 bc2:T57
A11	Effect_Type E8 Increase
R41	Effect_type_marker Arg1:E8 Arg2:T54	
T56	Cancer 1701 1710	luminal A
T57	Cancer 1715 1730	triple-negative
A12	Cancer_Type T57 TNBC_and_or_Basal_like
R42	Member Arg1:T46 Arg2:T48	
R43	Member Arg1:T46 Arg2:T49	
R44	Member Arg1:T46 Arg2:T50	
R45	Member Arg1:T46 Arg2:T52	
A13	Cancer_Type T50 TNBC_and_or_Basal_like
A14	Cancer_Type T48 Horm+HER2-Ki67Low
A15	Cancer_Type T49 HER2+
A16	Cancer_Type T52 Horm+HER2-Ki67+
A17	Cancer_Type T56 Horm+HER2-Ki67Low
T58	SNP 1741 1750	Rs3798577
T59	Effect_Type 1751 1760	decreased
T60	Association 1765 1769	risk
E9	Association:T60 snp_int:T58 bc:T61 bc2:T62
A18	Effect_Type E9 Decrease
R46	Effect_type_marker Arg1:E9 Arg2:T59	
T61	Cancer 1773 1782	luminal B
T62	Cancer 1787 1802	triple-negative
A19	Cancer_Type T62 TNBC_and_or_Basal_like
A20	Cancer_Type T61 Horm+HER2-Ki67+
T63	Entity 1837 1841	ESR1
T64	SNP 1842 1851	rs2881766
R47	SNP_coupled_gene Arg1:T64 Arg2:T63	
R48	SNP_coupled_gene Arg1:T44 Arg2:T63	
R49	SNP_coupled_gene Arg1:T33 Arg2:T63	
T65	Effect_Type 1865 1874	increased
T66	Cancer 1875 1888	breast cancer
T67	Association 1889 1893	risk
E10	Association:T67 bc:T66 snp_int:T64
A21	Effect_Type E10 Increase
R50	Effect_type_marker Arg1:E10 Arg2:T65	
T68	SNP 1898 1907	rs3798377
T69	Entity 1930 1942	Korean women
R51	Population_assignment Arg1:T68 Arg2:T69	
R52	Population_assignment Arg1:T64 Arg2:T69	
R53	Population_assignment Arg1:T58 Arg2:T69	
T70	Effect_Type 1908 1917	decreased
T71	Association 1922 1926	risk
E11	Association:T71 bc:T66 snp_int:T68
A22	Effect_Type E11 Decrease
R54	Effect_type_marker Arg1:E11 Arg2:T70	
A23	SNP_Type T24 Synonymous
A24	SNP_Type T25 Non-Coding
A25	SNP_Type T26 Non-Coding
R22	SNP_coupled_gene Arg1:T27 Arg2:T22	
R55	SNP_coupled_gene Arg1:T39 Arg2:T22	
R56	SNP_coupled_gene Arg1:T53 Arg2:T63	
